Cite
A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer.
MLA
Wang, Guochang, et al. “A Prospective Head-to-Head Comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer.” European Journal of Nuclear Medicine & Molecular Imaging, vol. 50, no. 10, Aug. 2023, pp. 3126–36. EBSCOhost, https://doi.org/10.1007/s00259-023-06283-4.
APA
Wang, G., Li, L., Zhu, M., Zang, J., Wang, J., Wang, R., Yan, W., Zhu, L., Kung, H. F., & Zhu, Z. (2023). A prospective head-to-head comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in patients with primary prostate cancer. European Journal of Nuclear Medicine & Molecular Imaging, 50(10), 3126–3136. https://doi.org/10.1007/s00259-023-06283-4
Chicago
Wang, Guochang, Linlin Li, Ming Zhu, Jie Zang, Jiarou Wang, Rongxi Wang, Weigang Yan, Lin Zhu, Hank F. Kung, and Zhaohui Zhu. 2023. “A Prospective Head-to-Head Comparison of [68Ga]Ga-P16-093 and [68Ga]Ga-PSMA-11 PET/CT in Patients with Primary Prostate Cancer.” European Journal of Nuclear Medicine & Molecular Imaging 50 (10): 3126–36. doi:10.1007/s00259-023-06283-4.